For Immediate Release

In2Bones Continues Driving Innovation with Launch of the Hercules^™ Suture Anchors and AlloAid^® Wedges

Memphis, Tenn., (February 23, 2021) – In2Bones Global, Inc. today announces the U.S. launch of its Hercules™ Suture Anchor System and AlloAid^® Wedges for lower extremity surgeries. These advanced-design implant systems expand the company’s already robust portfolio of pre-sterilized and OR-ready extremity products.

With the Hercules Suture Anchor System, In2Bones sees an opportunity for sales acceleration with soft tissue fixation for the multi-billion sports medicine market. The unique system provides surgeons two PEEK-based implant families, Fully-Threaded and Knotless.

Both anchor families feature proprietary, ultra-high molecular weight polyethylene (UHMWPE) sutures that enable an extremely strong and durable repair.

Highlights of the Hercules Suture Anchor System include:

• Radiolucent PEEK material with modulus similar to cortical bone
• Specific sizing for versatile applications, with excellent pullout strength¹
• Unique, Knotless Suture Anchor enabling tensioning after implantation
• Proprietary BightForce™ Suture featuring a smooth, silk-like suture surface that is gentle on soft tissues and surgeon gloves, and remains flexible and pliable throughout the repair procedure
• Anchors delivered sterile and assembled for increased OR efficiency

The new AlloAid Wedges are viewed as another best-in-class growth driver for In2Bones. The wedges are sterile, pre-shaped and sized specifically for the Cotton and Evans Osteotomies, both commonly performed during flatfoot reconstructive surgeries. A pre-sterilized instrument set is provided to allow precision implant sizing and placement.

The Hercules Suture Anchor and AlloAid Wedge Systems provide pull-through sales opportunities in previously unaddressed areas of the In2Bones portfolio of products. They are delivered pre-sterilized and OR-ready, providing logistical, quality, and cost benefits to the healthcare provider.

Savings from Single-Use Instrument Sets
There are tremendous benefits to providers who select implants that include sterile, single-use instruments. These include:

• Cost savings of as much as $400-$500 per surgery
• Increased efficiencies by eliminating long lead times, costs and delays related to on-site sterilizing processes
• Reduced risk of post-operative surgical site infections (SSIs)